Novantrone
NDC Package 44087-1520-1
Package Information
Novantrone is a . Marketed by Emd Serono, Inc., this product is identified by NDC 44087-1520 and is authorized under FDA application NDA019297.
Identification & Billing
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 44087 - Emd Serono, Inc.
- 44087-1520 - Novantrone
- 44087-1520-1 - 10 mL in 1 VIAL, MULTI-DOSE
- 44087-1520 - Novantrone
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 44087-1520-1 identifies a specific commercial package of 10 ml in 1 vial, multi-dose of Novantrone, labeled by Emd Serono, Inc.. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Emd Serono, Inc. on December 23, 1987. The current certification is valid through June 08, 2011.
How is this Emd Serono, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 44087152001. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.